Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
Juyeun Lee, Michael Nicosia, Ellen S. Hong, et al.
Cancer Discovery (2023) Vol. 13, Iss. 9, pp. 2090-2105
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 60
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1105-1123.e8
Closed Access | Times Cited: 57
Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications
Tong Xiao, Juyeun Lee, Timothy D. Gauntner, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 338-355
Closed Access | Times Cited: 22
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu, Zhou Fei, Heba Ali, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1354-1375
Open Access | Times Cited: 21
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Julie K. Jadlowsky, Elizabeth O. Hexner, Amy Marshall, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 5
Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma
Lizhi Pang, Songlin Guo, Fatima Khan, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101238-101238
Open Access | Times Cited: 23
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 13
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Qian Liu, Emma Adhikari, Daniel Lester, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma
Sara Hiller-Vallina, Lucía Mondéjar-Ruescas, Marta Caamaño-Moreno, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 7, pp. 1213-1227
Open Access | Times Cited: 10
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Anthony Z. Wang, Bryce L. Mashimo, Maximilian O. Schaettler, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1106-1131
Closed Access | Times Cited: 9
Epigenetic developmental mechanisms underlying sex differences in cancer
Joshua B. Rubin, Tamara Abou-Antoun, Joseph E. Ippolito, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 8
Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants
Nicolina Jovanovich, Ahmed Habib, Akanksha Chilukuri, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 6
Epigenetic regulation of tumor-immune symbiosis in glioma
Yang Liu, Heba Ali, Fatima Khan, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 429-442
Open Access | Times Cited: 6
Leptomeningeal dissemination in H3 K27M- mutant diffuse midline gliomas: clinical characteristics, risk factors, and prognostic insights
Shuai Zhong, Jinyi Zuo, Xiaojun Fu, et al.
Journal of Neuro-Oncology (2025)
Open Access
The Complexity of Malignant Glioma Treatment
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
Sex hormones, the anticancer immune response, and therapeutic opportunities
Fabio Conforti, Laura Pala, Diletta Di Mitri, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 343-360
Open Access
Single-cell spatial transcriptomics unravels cell states and ecosystems associated with clinical response to immunotherapy
Ziena Abdulrahman, Roderick C. Slieker, Daniel McGuire, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e011308-e011308
Open Access
Sex chromosome complement interacts with gonadal hormones in determining regional-specific neuroactive steroid levels in plasma, hippocampus, and hypothalamus. A study using the four core genotype mouse model
Lucia Cioffi, Daniela Grassi, Silvia Diviccaro, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 241, pp. 106514-106514
Open Access | Times Cited: 3
T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer
Michelle Brennan, David DeBruin, Chinye Nwokolo, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 8, pp. 956-963
Closed Access | Times Cited: 3
Microglia and macrophages in glioblastoma: landscapes and treatment directions
Georgios Solomou, Adam M. H. Young, Harry Bulstrode
Molecular Oncology (2024)
Open Access | Times Cited: 3
Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours
Ling Ni
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 3
Sex differences in disease: sex chromosome and immunity
Zuxi Feng, Minjing Liao, Liansheng Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The Effect of Sex on the Therapeutic Efficiency of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
Xing‐Yu Zhong, Jian‐Xuan Sun, Na Zeng, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 382-382
Open Access | Times Cited: 2
Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
Sanghee Lim, Minhye Kwak, Jeong Han Kang, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis
Erin E. Mulkearns-Hubert, Nicole Hajdari, Ellen S. Hong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top